These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 15631024)
1. Assessment of lipid peroxidation and serum vitamin E concentration in dogs with immune-mediated hemolytic anemia. Pesillo SA; Freeman LM; Rush JE Am J Vet Res; 2004 Dec; 65(12):1621-4. PubMed ID: 15631024 [TBL] [Abstract][Full Text] [Related]
2. Potentially antigenic RBC membrane proteins in dogs with primary immune-mediated hemolytic anemia. Tan E; Bienzle D; Shewen P; Kruth S; Wood D Vet Clin Pathol; 2012 Mar; 41(1):45-55. PubMed ID: 22315967 [TBL] [Abstract][Full Text] [Related]
3. Case-control study of plasma mean platelet component concentration and survival analysis for dogs with immune-mediated hemolytic anemia. Zoia A; Gerou-Ferriani M; Drigo M; Caldin M J Am Vet Med Assoc; 2018 Jun; 252(11):1384-1392. PubMed ID: 29772969 [TBL] [Abstract][Full Text] [Related]
4. Comparison of cytokine responses between dogs with sepsis and dogs with immune-mediated hemolytic anemia. Johnson V; Burgess B; Morley P; Bragg R; Avery A; Dow S Vet Immunol Immunopathol; 2016 Nov; 180():15-20. PubMed ID: 27692090 [TBL] [Abstract][Full Text] [Related]
5. Assessment of degree of oxidative stress and antioxidant concentrations in dogs with idiopathic dilated cardiomyopathy. Freeman LM; Brown DJ; Rush JE J Am Vet Med Assoc; 1999 Sep; 215(5):644-6. PubMed ID: 10476709 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil Extracellular Traps in Plasma from Dogs with Immune-mediated Hemolytic Anemia. Lawson C; Smith SA; O'Brien M; McMichael M J Vet Intern Med; 2018 Jan; 32(1):128-134. PubMed ID: 29214674 [TBL] [Abstract][Full Text] [Related]
7. Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy. Grobman M; Outi H; Rindt H; Reinero C J Vet Intern Med; 2017 Sep; 31(5):1430-1440. PubMed ID: 28804921 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and antioxidant status in type 1 diabetes mellitus. Vessby J; Basu S; Mohsen R; Berne C; Vessby B J Intern Med; 2002 Jan; 251(1):69-76. PubMed ID: 11851867 [TBL] [Abstract][Full Text] [Related]
9. Perinuclear antineutrophil cytoplasmic autoantibodies in dogs infected with various vector-borne pathogens and in dogs with immune-mediated hemolytic anemia. Karagianni AE; Solano-Gallego L; Breitschwerdt EB; Gaschen FP; Day MJ; Trotta M; Wieland B; Allenspach K Am J Vet Res; 2012 Sep; 73(9):1403-9. PubMed ID: 22924722 [TBL] [Abstract][Full Text] [Related]
10. Characterisation of the Immunophenotype of Dogs with Primary Immune-Mediated Haemolytic Anaemia. Swann JW; Woods K; Wu Y; Glanemann B; Garden OA PLoS One; 2016; 11(12):e0168296. PubMed ID: 27942026 [TBL] [Abstract][Full Text] [Related]
11. Case-control study of blood type, breed, sex, and bacteremia in dogs with immune-mediated hemolytic anemia. Miller SA; Hohenhaus AE; Hale AS J Am Vet Med Assoc; 2004 Jan; 224(2):232-5. PubMed ID: 14736067 [TBL] [Abstract][Full Text] [Related]
12. Cell-Free DNA and DNase Activity in Dogs with Immune-Mediated Hemolytic Anemia. Jeffery U; Ruterbories L; Hanel R; LeVine DN J Vet Intern Med; 2017 Sep; 31(5):1441-1450. PubMed ID: 28833583 [TBL] [Abstract][Full Text] [Related]
13. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration. Reimann MJ; Häggström J; Møller JE; Lykkesfeldt J; Falk T; Olsen LH J Vet Intern Med; 2017 Mar; 31(2):295-302. PubMed ID: 28132441 [TBL] [Abstract][Full Text] [Related]
14. Serum interleukin 17 concentrations in dogs with immune-mediated hemolytic anemia. Cuq B; Blois SL; Bédard C; Wood RD; Abrams-Ogg AC; Beauchamp G; Wood GA J Vet Intern Med; 2021 Jan; 35(1):217-225. PubMed ID: 33219716 [TBL] [Abstract][Full Text] [Related]
15. Dogs cast NETs too: Canine neutrophil extracellular traps in health and immune-mediated hemolytic anemia. Jeffery U; Kimura K; Gray R; Lueth P; Bellaire B; LeVine D Vet Immunol Immunopathol; 2015 Dec; 168(3-4):262-8. PubMed ID: 26574161 [TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies in dogs with immune mediated hemolytic anemia, spontaneous thrombosis, and hyperadrenocorticism. Miller AG; Dow S; Long L; Olver CS J Vet Intern Med; 2012; 26(3):614-23. PubMed ID: 22489954 [TBL] [Abstract][Full Text] [Related]
17. C-reactive protein concentration in dogs with primary immune-mediated hemolytic anemia. Griebsch C; Arndt G; Raila J; Schweigert FJ; Kohn B Vet Clin Pathol; 2009 Dec; 38(4):421-5. PubMed ID: 19392754 [TBL] [Abstract][Full Text] [Related]
19. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs. Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140 [TBL] [Abstract][Full Text] [Related]
20. Anti-endothelial cell antibodies in dogs with immune-mediated hemolytic anemia and other diseases associated with high risk of thromboembolism. Wells R; Guth A; Lappin M; Dow S J Vet Intern Med; 2009; 23(2):295-300. PubMed ID: 19192144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]